Brown Advisory’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Brown Advisory’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,936	Closed	-$663K	–	1327
2019 Q1	$663K	Sell	3,936 -71	-2%	-$10.6K	﹤0.01%	911
2018 Q4	$390K	Sell	4,007 -252	-6%	-$33.1K	﹤0.01%	1004
2018 Q3	$735K	Sell	4,259 -135	-3%	-$19.5K	﹤0.01%	890
2018 Q2	$613K	Buy	4,394 +2,555	+139%	+$363K	﹤0.01%	928
2018 Q1	$207K	Buy	1,839 +143	+8%	+$18K	﹤0.01%	1101
2017 Q4	$224K	Buy	+1,696	New	+$199K	﹤0.01%	1133

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Brown Advisory's GWPH Position: Q2 2019 in Review

Brown Advisory sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 3,936 shares — an estimated $663K sold.

Brown Advisory first reported a position in GWPH in Q4 2017 and held it in 6 quarters. The position peaked at $735K in Q3 2018. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

Brown Advisory reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Brown Advisory sold 3,936 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $663K.
Brown Advisory first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 6 quarters.
Brown Advisory's GW Pharmaceuticals Plc American Depositary Shares position peaked at $735K in Q3 2018.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Brown Advisory's 13F filing for Q2 2019, filed 12 Aug 2019.